Literature DB >> 19161993

Perillyl alcohol attenuates Ras-ERK signaling to inhibit murine skin inflammation and tumorigenesis.

Sandeep Chand Chaudhary1, M Sarwar Alam, M S Siddiqui, M Athar.   

Abstract

In the present study, the chemopreventive effect of topical application of perillyl alcohol (POH) on 9,10-dimethylbenz(a)anthracene (DMBA)-initiated and 12-O-tetradecanoylphorbol-13-acetate (TPA)-promoted skin tumorigenesis and its possible mechanisms of action in Swiss albino mice were investigated. We evaluated the effect of pretreatment of POH (6 and 12 mg/kg body weight) on TPA (2 microg/200 microl of acetone)-induced skin edema, hyperplasia, peroxidase damage and modulation in activities of catalase, glutathione reductase, glutathione peroxidase, glutathione-S-transferase and reduced glutathione contents. Application of POH 30 min prior to TPA treatment, showed a protective effect in almost all the investigated parameters. Additionally, pretreatment with POH showed a significant inhibition of ornithine decarboxylase (ODC) activity and [(3)H] thymidine incorporation into epidermal DNA. In promotion phase, a significant reduction was found in tumor incidence and tumor burden in mice pretreated with POH (12 mg/kg body weight) with extension of the latency period from 4 to 8 weeks as compared to those treated with TPA alone. POH significantly suppressed the Ras/Raf/ERK pathway and induced apoptosis in Swiss albino mice skin. Our findings suggested that the chemopreventive efficacy of POH is probably due to the inhibition of oxidative stress responses, inhibition of the Ras cell proliferation pathway and induction of apoptosis in murine skin tumor promotion phase.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19161993     DOI: 10.1016/j.cbi.2008.12.016

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  17 in total

1.  Nonsurgical innovations in the treatment of nonmelanoma skin cancer.

Authors:  Sadegh Amini; Martha H Viera; Whitney Valins; Brian Berman
Journal:  J Clin Aesthet Dermatol       Date:  2010-06

Review 2.  Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy.

Authors:  Thomas C Chen; Clovis O Da Fonseca; Axel H Schönthal
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

3.  Inhibition of perillyl alcohol on cell invasion and migration depends on the Notch signaling pathway in hepatoma cells.

Authors:  Yong Ma; Jianmin Bian; Feng Zhang
Journal:  Mol Cell Biochem       Date:  2015-10-17       Impact factor: 3.396

4.  Analysis of EGF+61A>G polymorphism and EGF serum levels in Brazilian glioma patients treated with perillyl alcohol-based therapy.

Authors:  Francisco das Chagas Abreu da Silveira; Bruno de Almeida Lopes; Clovis Orlando da Fonseca; Thereza Quirico-Santos; Izabel Christina Nunes de Palmer Paixão; Lidia Maria da Fonte de Amorim
Journal:  J Cancer Res Clin Oncol       Date:  2012-04-06       Impact factor: 4.553

5.  Dynamic proteomic overview of glioblastoma cells (A172) exposed to perillyl alcohol.

Authors:  Juliana de Saldanha da Gama Fischer; Lujian Liao; Paulo C Carvalho; Valmir C Barbosa; Gilberto B Domont; Maria da Gloria da Costa Carvalho; John R Yates
Journal:  J Proteomics       Date:  2010-01-18       Impact factor: 4.044

6.  Antineoplastic activities of MT81 and its structural analogue in Ehrlich ascites carcinoma-bearing Swiss Albino mice.

Authors:  Sujata Maiti Choudhury; Malaya Gupta; Upal Kanti Majumder
Journal:  Oxid Med Cell Longev       Date:  2010 Jan-Feb       Impact factor: 6.543

7.  Disruption of an hTERT-mTOR-RAPTOR protein complex by a phytochemical perillyl alcohol and rapamycin.

Authors:  Tabetha Sundin; Dennis M Peffley; Patricia Hentosh
Journal:  Mol Cell Biochem       Date:  2013-01-03       Impact factor: 3.396

Review 8.  Cancer prevention with promising natural products: mechanisms of action and molecular targets.

Authors:  Poyil Pratheeshkumar; Chakkenchath Sreekala; Zhuo Zhang; Amit Budhraja; Songze Ding; Young-Ok Son; Xin Wang; Andrew Hitron; Kim Hyun-Jung; Lei Wang; Jeong-Chae Lee; Xianglin Shi
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

9.  Perillyl alcohol for pediatric TP53- and RAS-mutated SHH-medulloblastoma: an in vitro and in vivo translational pre-clinical study.

Authors:  Marcela de Oliveira Silva; Graziella Ribeiro de Sousa; Sarah Capelupe Simões; Patrícia Nicolucci; Edwin Tamashiro; Fabiano Saggioro; Ricardo Santos de Oliveira; María Sol Brassesco
Journal:  Childs Nerv Syst       Date:  2021-04-22       Impact factor: 1.475

10.  Na/K-ATPase as a target for anticancer drugs: studies with perillyl alcohol.

Authors:  Diogo Gomes Garcia; Hugo Caire de Castro-Faria-Neto; Camila Ignácio da Silva; Kauê Francisco Correa de Souza e Souza; Cassiano Felippe Gonçalves-de-Albuquerque; Adriana Ribeiro Silva; Lidia Maria da Fonte de Amorim; Aline Soares Freire; Ricardo Erthal Santelli; Luan Pereira Diniz; Flávia Carvalho Alcantara Gomes; Mauro Velho de Castro Faria; Patrícia Burth
Journal:  Mol Cancer       Date:  2015-05-15       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.